Alexithymia in patients recently diagnosed with cancer

Détails

ID Serval
serval:BIB_7B8E50363975
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Collection
Publications
Titre
Alexithymia in patients recently diagnosed with cancer
Titre de la conférence
14th Annual Meeting of the European Association for Consultation Liaison Psychiatry and Psychosomatics (EACLPP)
Auteur(s)
Stiefel F., Krenz S., Forni V., Zdrojewski C., Aymon N., Stagno D., Luthi F., Leyvraz S., Rousselle I., Ludwig G.
Adresse
Hungary, Budapest, June 30 th-July 2, 2011
ISBN
0022-3999
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
70
Série
Journal of Psychosomatic Research
Pages
616
Langue
anglais
Notes
Publication type : Meeting Abstract
Résumé
Background: Contrary to the frequent assumption that alexithymia is a rather static personality trait hampering psychotherapeutic approaches, we have observed that cancer patients who qualify for the criteria of alexithymia may benefit from psychotherapy. Therefore, in patients facing a cancer diagnosis, alexithymia can often be considered as a state due to the threat of the disease (secondary alexithymia).Aims: To identify prevalence of alexithymia in newly diagnosed cancer patients and to document its evolution with and without psychotherapeutic interventions.Methods: Between 2006 and summer 2009, every newpatient of the Oncology Service of the University Hospital Lausanne was invited to benefit from psychotherapeutic support. Accepting patients were randomly assigned to a psychotherapeutic intervention or to a 4-month waiting list. Psychotherapies were formalized as psychodynamic-oriented short interventions (1-4 sessions) or brief psychodynamic psychotherapies (16 sessions). Patients who declined psychotherapeutic support were asked to participate in an observational group. Socio-demographic and medical data, alexithymia (TAS), anxiety and depression (SCL-90, HADS) and quality of life (EORTC) of participants of all groups were recorded at base line and at 1, 4, 8 and 12-months follow-up. Results: Of the 419 patients included, 190 desired psychotherapeutic support (94 were assigned to an immediate and 96 to a delayed intervention) and 229 patients accepted to be followed in the observational group. A very high proportion, almost 2/3 of the patients in all groups, qualified for alexithymia. With regard to the evolution of alexithymia, no significant changes were observed within and between groups and psychological symptoms also remained almost stable.Conclusions: Secondary alexithymia seems to be highly prevalent in newly diagnosed cancer patients. This raises important clinical and scientific questions: are these patients deprived from psychological support? How should interventions be conceptualized? Are interventions necessary and beneficial? Does alexithymia neutralize the effect of interventions on symptoms of anxiety and depression? Which outcome should be chosen for patients with secondary alexithymia?Keywords: Alexithymia, cancer, psycho-oncology, psychotherapy, secondary alexithymia
Mots-clé
Alexithymia, cancer, psycho-oncology, psychotherapy, secondary alexithymia,
Web of science
Création de la notice
29/06/2011 12:56
Dernière modification de la notice
20/08/2019 14:37
Données d'usage